These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 17180767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE, Lustigman AB.
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract] [Full Text] [Related]

  • 4. It's only skin deep: FDA regulation of skin care cosmetics claims.
    Liang BA, Hartman KM.
    Cornell J Law Public Policy; 1999; 8(2):249-80. PubMed ID: 11010667
    [No Abstract] [Full Text] [Related]

  • 5. Medical device labeling and advertising: an overview.
    Basile EM, Armentrout E, Reeves KN.
    Food Drug Law J; 1999; 54(4):519-33. PubMed ID: 11824451
    [Abstract] [Full Text] [Related]

  • 6. Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
    Soller RW, Rice LG, Ambrose PJ.
    Food Drug Law J; 2007; 62(2):375-86. PubMed ID: 17632967
    [No Abstract] [Full Text] [Related]

  • 7. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework?
    Basile EM, Lorell BH.
    Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
    Hayes TA.
    Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
    [No Abstract] [Full Text] [Related]

  • 13. Legal overview of likely FDA regulation of Internet promotion.
    Scheineson MJ.
    Food Drug Law J; 1996 Jun; 51(4):697-716. PubMed ID: 11797736
    [No Abstract] [Full Text] [Related]

  • 14. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B.
    J Natl Cancer Inst; 2005 Dec 21; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract] [Full Text] [Related]

  • 15. Regulating drug promotion on the Internet.
    Bannon L.
    Food Drug Law J; 1999 Dec 21; 54(4):599-621. PubMed ID: 11824457
    [No Abstract] [Full Text] [Related]

  • 16. A global view of the First Amendment constraints of FDA.
    Carver KH.
    Food Drug Law J; 2008 Dec 21; 63(1):151-215. PubMed ID: 18561459
    [No Abstract] [Full Text] [Related]

  • 17. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN, Ferrari PL, Murphy AM, Hyman, Phelps & McNamara, P.C., Washington, D.C., USA.
    Food Drug Law J; 2003 Dec 21; 58(3):331-45. PubMed ID: 14626233
    [No Abstract] [Full Text] [Related]

  • 18. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM.
    Food Drug Law J; 1996 Dec 21; 51(4):631-5. PubMed ID: 11797732
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ.
    Food Drug Law J; 1996 Dec 21; 51(2):323-9. PubMed ID: 11822325
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.